Physician profile
John David Cramer
NPI 1093078834
$1,466.46
in general payments reported to CMS, 2019-2025
9 companies · $557 in 2025
The $557 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $185 · 2022: $123 · 2024: $602 · 2025: $557.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $670 · Food and Beverage: $489.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $670.00 |
| Food and Beverage | $489.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verathon INC. | $550.00 | 2024 | Bronchoscope |
| Kls-Martin L.P. | $184.81 | 2019 | |
| Aerin Medical INC. | $160.69 | 2025 | |
| Janssen Research & Development, LLC | $140.21 | 2025 | |
| Tactile Systems Technology INC | $136.55 | 2022-2024 | Flexitouch Plus, Entre Plus |
| Becton, Dickinson and Company | $120.00 | 2025 | |
| Merck Sharp & Dohme LLC | $75.28 | 2024-2025 | Keytruda |
| Ethicon US, LLC | $66.28 | 2024-2025 | Harmonic, Enseal, Megadyne |
| Ucb, INC. | $32.64 | 2025 | Bimzelx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Cramer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.